Markets, explained.

A Soft Payrolls Tell Flips the Rate Script — and Tech Runs With It

Three Chokepoints, One Buffer: Why Hormuz, the Black Sea, and the Mecca Pact Are Rewiring Risk Premiums

The Nasdaq Is the Cleanest Tell on a Payroll-Miss Rally

July's -23K payroll miss with 103K in negative revisions is fueling a semiconductor-led Nasdaq rally while cyclicals lag. The market is pricing Fed cuts against a labor market that is actually contracting — a 60/40 trade with real tension underneath.

SpaceX Lockup Tests the Great Equity-Supply Reversal

SpaceX's first lockup expiry could more than double its public float, arriving just as JPMorgan estimates $1.5 trillion in net equity supply over two years. The demand side faces concentration risk from record ETF inflows.

Three Fronts at Once: Polysilicon Tariffs, Hormuz Ceasefire, and Taiwan Drills Hit Markets on the Same Week

The US extended its tech war into polysilicon with a 15% tariff, a two-week Iran ceasefire kept oil volatile near $82, and Chinese coast guard drills east of Taiwan signaled a trade quarantine rehearsal — all in the same week the Dow snapped a five-day win streak as oil and yields rose together.

When Record Profits Meet a Resurgent Oil Risk Premium

Q2 earnings growth of 47.4% pushed the S&P 500 to a record close above 7,700, but a Thursday breather led by the Dow's 464-point drop shows investors repricing Iran-Hormuz oil risk. Pre-market Friday, QQQ is quietly bouncing.

SpaceX Unlock Defies Gravity: What $100 Billion in Freed Shares Means for the IPO Pipeline

SpaceX's first post-IPO lockup expiration freed roughly $100 billion in insider shares on August 6, more than doubling the public float. The stock rose 6% instead of cratering. The staggered unlock schedule and the broader IPO pipeline — Anthropic, Braveheart Bio, Jersey Mike's — now hang on whether that calm holds.

Hormuz Deal Optimism Meets a Tanker Freeze: The Widening Gap Between Oil Prices and Physical Reality

Oil markets are pricing a Hormuz reopening that hasn't materialized in tanker traffic. Near-zero transits, a Houthi blockade of the alternative route, and fresh China trade retaliation create a fragile setup where any diplomatic setback could snap prices back sharply.

Oil, Yields, and AI: The Market Is Trading Two Stories at Once

XLE's 1.5% gain on Iran-driven oil strength is the cleanest tell in Thursday's tape. Rising Treasury yields are pressuring rate-sensitive financials — Goldman Sachs fell 2.6% — while Microsoft's post-earnings momentum and Eli Lilly's GLP-1 surge keep the AI and healthcare narratives alive. Tomorrow's nonfarm payrolls is the next catalyst.

SpaceX Lockup Test: 911 Million Shares Unlock as IPO Pipeline Surges and Reg NMS Faces Rescission

SpaceX's first lockup expiry frees up to 911.5 million insider shares on August 6, potentially tripling the public float of a stock already down 49% from its June high. The test arrives as biotech IPOs accelerate, July saw $29.3 billion in new listings, and the SEC moves to rescind Regulation NMS's trade-through rule.

AI Earnings Reset Meets a Hormuz Reversal: The Market's Split Close

The S&P 500 slipped 0.15% as four AI-linked stocks shed roughly $68 billion in market value despite earnings beats, while energy surged on Brent's jump after Iran published restrictive Strait of Hormuz transit terms. Microsoft's $90 billion quarter offered a counter-narrative, and Friday's payrolls loom.

SpaceX Lockup Test Meets Biotech IPO Pipeline as SEC Rewrites Market Plumbing

SpaceX's first lockup expiry could more than double the public float on August 6. The August IPO calendar is biotech-heavy. And the SEC's proposed rescission of Reg NMS Rules 611 and 610(e) represents the most significant equity market-structure change in two decades.